-
-
-
-
-
-
-
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
-
-
-
-
-
-
-
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
-
-
-
-
-
-
-
SWK Holdings (SWKH) Provides Portfolio Update
-
-
-
-
-
-
-
Journey Medical Corp (DERM) Appoints Joseph Benesch as CFO
-
-
-
-
-
-
-
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of
-
1,158,054 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

